Schizoaffective disorder doesn’t have a single trigger. It develops from a combination of genetic vulnerability, brain chemistry differences, and environmental stressors that interact over time. Some of these factors begin before birth, others accumulate during childhood, and certain experiences in adolescence or early adulthood can push a vulnerable person toward a first episode. Understanding these layers helps explain why some people develop the condition and others with similar backgrounds do not.
Genetic Vulnerability Sets the Foundation
The strongest known risk factor is family history. Heritability for schizophrenia is estimated at 64%, and for bipolar disorder 59%. Schizoaffective disorder shares genetic overlap with both conditions, and people with the diagnosis are often counted as “affected” in genetic studies of either one. Having a first-degree relative (a parent or sibling) with schizophrenia, bipolar disorder, or schizoaffective disorder raises your risk substantially compared to the general population.
Genetics alone don’t determine the outcome, though. Most people with a family history never develop schizoaffective disorder. What genes appear to do is lower the threshold, making the brain more sensitive to the environmental and biological triggers described below. Think of it as a loaded foundation: something else still has to build on it.
Brain Chemistry and Structure
Two chemical signaling systems in the brain play central roles. The first involves dopamine, a messenger chemical tied to motivation, pleasure, and how the brain filters reality. People who develop psychotic symptoms tend to have elevated dopamine production and release in a deep brain region called the striatum. This overactivity is linked to hallucinations, delusions, and disorganized thinking.
The second system involves glutamate, the brain’s most common excitatory signal. Receptors that respond to glutamate appear to function at lower-than-normal levels in people with schizophrenia spectrum disorders. When researchers block these receptors in healthy volunteers, the result is symptoms that closely mimic psychosis. Both genetic and environmental risk factors seem to disrupt these two systems, and they influence each other, meaning dysfunction in one can worsen the other.
Brain imaging studies also reveal structural differences. People with schizoaffective disorder and related conditions tend to have reduced gray matter volume in several areas: the hippocampus (involved in memory), the thalamus (a relay station for sensory information), the superior temporal gyrus (which processes sound and language), and the anterior cingulate cortex (which helps regulate emotions and decision-making). In people who experience auditory hallucinations, specific regions involved in processing sound show even greater volume reductions. These structural changes likely develop gradually and may reflect both genetic predisposition and environmental damage.
Prenatal Infections and Birth Complications
Some triggers act long before symptoms appear. Certain infections during pregnancy significantly increase the child’s risk of developing a psychotic disorder later in life. Rubella exposure during pregnancy is associated with a 10- to 20-fold increase in schizophrenia risk among offspring. Influenza during the first trimester raises risk roughly 7-fold, while exposure during early to mid-pregnancy carries about a 3-fold increase. Toxoplasmosis, a parasitic infection commonly contracted from undercooked meat or cat litter, is linked to a 2.5-fold increase.
The mechanism likely involves the mother’s immune response rather than the infection itself. Elevated levels of inflammatory proteins in maternal blood during the second trimester, particularly a signaling molecule called interleukin-8, have been found at nearly twice the normal levels in mothers whose children later developed schizophrenia. This suggests that inflammation during critical windows of fetal brain development can alter how the brain forms and wires itself, creating vulnerabilities that surface decades later.
Childhood Trauma and Early Stress
Adverse experiences during childhood are consistently linked to higher rates of psychotic disorders. The types of trauma most strongly associated include physical abuse, sexual abuse, emotional abuse, and neglect. But the category extends beyond direct maltreatment. Growing up in a household with domestic violence, ongoing substance abuse, or a parent with serious mental illness also qualifies. Interpersonal loss, such as the death of a parent or parental divorce before age 17, adds to the cumulative burden.
These experiences don’t cause schizoaffective disorder on their own. Rather, they appear to alter the stress response system in ways that make the brain more reactive to future challenges. A child whose stress hormones are chronically elevated may develop a brain that is primed to over-respond to threats, which can amplify the dopamine dysregulation already described. The more types of adversity a person experiences, the greater the cumulative effect on risk.
Cannabis and Stimulant Use
Substance use is one of the most well-documented environmental triggers for a first psychotic episode, particularly in people who already carry genetic vulnerability. Cannabis is the most studied. THC, the psychoactive compound in marijuana, directly interacts with the brain’s dopamine system. In controlled experiments, intravenous THC produces dose-dependent increases in both positive psychotic symptoms (like hallucinations and paranoia) and negative symptoms (like emotional flatness) in healthy volunteers. In people with schizophrenia in remission, the effects are even more pronounced.
Daily-life studies confirm this pattern outside the lab. During periods of cannabis use, people report more unusual perceptions. Those who already have some vulnerability to psychosis are significantly more likely to experience strange impressions and perceptual distortions when using cannabis compared to people without that vulnerability. Among those who develop psychotic disorders, regular cannabis use is associated with more severe positive symptoms, more frequent relapses, and higher rates of hospitalization.
Stimulants like methamphetamine and cocaine also increase dopamine activity and can trigger psychotic episodes. The risk is highest with heavy or prolonged use, but in a genetically predisposed person, even moderate use may be enough to initiate symptoms that persist after the drug wears off.
Age and Gender Patterns
Schizoaffective disorder typically emerges in late adolescence or early adulthood, following the general pattern of schizophrenia spectrum conditions. Men tend to develop first symptoms between ages 18 and 25, while women more commonly experience onset between 25 and 35. Women also show a second, smaller peak in onset after age 40, possibly related to declining estrogen levels, which are thought to have a protective effect against psychosis earlier in life.
Men have a somewhat higher incidence of new cases, with one large meta-analysis finding a male-to-female ratio of about 1.4 to 1 for schizophrenia. Overall prevalence, meaning the total number of people living with the condition at any given time, is roughly equal between genders. This suggests that while men are more likely to develop the condition and tend to do so earlier, women catch up over time partly due to that second peak in later life.
How These Triggers Interact
The most accurate way to think about what triggers schizoaffective disorder is as a stress-vulnerability model. Genes and prenatal factors establish a baseline level of vulnerability. Childhood adversity can raise that baseline further. Then, during a critical developmental window in adolescence or early adulthood, when the brain is undergoing significant reorganization, an acute stressor pushes a vulnerable person past a threshold. That stressor might be heavy cannabis use, a major life disruption, sleep deprivation, social isolation, or a combination.
This explains why two siblings with similar genetics can have different outcomes. One might avoid significant substance use and trauma, never crossing the threshold. The other might encounter several additional risk factors at the wrong time. It also explains why some people develop symptoms after a single identifiable event while others experience a slow, gradual onset with no obvious precipitant. The triggers are cumulative, and the tipping point varies from person to person.